Sygnature Discovery Limited
Amy Cantrell is an accomplished Senior Scientist at Sygnature Discovery since January 2022. Prior to this role, Amy served as a Scientist at AstraZeneca for 17 years, from October 2005 until December 2022. Amy's educational background includes studies at the University of Chester and Reaseheath College.
This person is not in any offices
Sygnature Discovery Limited
2 followers
Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.